We are continuing to liaise with NHS England (which can provide advice to ICBs on market entry issues) and PCSE to try to help reduce the overall timescales for the determination of applications. We have produced a guidance document with 10 key points to support applicants and their referees with their market entry applications. We [...]
The post Market Entry Applications – 10 Key Points Guidance appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has been consulting on proposals to update the Medicines Act 1968 and Human Medicines Regulations 2012 on the supervision of the dispensing and supply of medicines. Their two proposals concerning community pharmacy, both subject to appropriate pharmacist authorisation, are: Pharmacy technicians dispensing and supplying medicines, or supervising [...]
The post Community Pharmacy England response to the DHSC consultation on supervision appeared first on Community Pharmacy England.
This week the MHRA announced that codeine linctus would be reclassified to a prescription-only medicine because of the risk of abuse and addiction that comes with it being available over-the-counter. Please see more information here: Codeine linctus to be reclassified to a prescription-only medicine because of risk of abuse and addiction – GOV.UK (www.gov.uk) We [...]
The post Codeine Linctus reclassification from P to POM appeared first on Community Pharmacy England.
This week the MHRA has issued new safety and educational materials for patients and healthcare professionals to support the implementation of the new regulatory measures. These materials include: Updated Patient Guide Updated Healthcare Professional Guide Updated Annual Risk Acknowledgement Form New Risk Acknowledgment Form for male patients starting valproate Patient Card Pharmacy Poster Warning Stickers [...]
The post MHRA issues new materials for valproate safety measures appeared first on Community Pharmacy England.
Community Pharmacy England has been increasingly aware of delays in the market entry process, which includes change of ownership applications. The process is administered by Primary Care Support England (PCSE) with decisions being made by integrated care boards (ICBs). The delays appear to be due to a number of factors and issues including: increased pharmacy [...]
The post Delays with market entry applications appeared first on Community Pharmacy England.
Recent Comments